Viability of HEMA-MMA microencapsulated model hepatoma cells in rats and the host response.
Small diameter hydroxyethyl methacrylate-methyl methacrylate (HEMA-MMA; 75% HEMA) microcapsules containing an aggregate of viable rat hepatoma H4IIEC3 cells, after implantation into an omental pouch in Wistar rats, contained viable cells at 7 days but not 14 days. A similar transplantation of microencapsulated aggregates of human hepatoma HepG2 cells did not result in viable cells even at 7 days. The loss of viability was attributed to the tissue reaction, because both encapsulated cell types remained viable in vitro. However, it is not clear if the cells lost their viability in vivo, leading to the aggressive tissue reaction or if the latter caused the cells to starve or otherwise die. The tissue reactions to microcapsules containing rat or human hepatoma cells at day 1 was one cell layer thick and avascular. At later times, tissue reactions were comprised of three regions: macrophages, fibroblasts, and some foreign body giant cells apposed to the polymer membrane, a dense region of fibroblasts and collagen, and a region of vascularized granulation tissue. Prompt vascularization of the tissue reactions occurred after 4 days and was maintained for up to 14 days. Even at 14 days, immune cells were observed, suggesting a continued immune response toward antigens shed from the encapsulated cells.
Babensee
J E
JE
Department of Chemical Engineering and Applied Chemistry, Institute for Biomaterials and Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada.
Sefton
M V
MV
D000818:Animals; D001672:Biocompatible Materials; D002214:Capsules; D002470:Cell Survival; D006801:Humans; D008114:Liver Neoplasms, Experimental / Q000276:immunology* / Q000473:pathology; D008297:Male; D008768:Methylmethacrylates; D009368:Neoplasm Transplantation; D011102:Polyhydroxyethyl Methacrylate; D051381:Rats; D017208:Rats, Wistar; D014183:Transplantation, Heterologous; D014184:Transplantation, Homologous; D014407:Tumor Cells, Cultured
D001672:Biocompatible Materials; D002214:Capsules; D008768:Methylmethacrylates; D011102:Polyhydroxyethyl Methacrylate; C040206:HTR composite